The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Leckie, M. J., Brinke, A. T., Khan, J., Diamant, Z., O'Connor, B. J., Walls, C. M., Mathur, A. K., Cowley, H. C., Chung, K. F., Djukanovic, R., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03496-6 · Cited by 1,814
Self-citationAnti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., & Santoro, M. G. (2000) · Nature · doi:10.1038/47520 · Cited by 1,310
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., Sugamura, K., Nakamura, M., Takano, S., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.255 · Cited by 1,099
Grosser, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27291 · Cited by 1,027
Ying, S., O’Connor, B., Ratoff, J., Meng, Q., Mallett, K., Cousins, D., Robinson, D., Zhang, G., Zhao, J., Lee, T. H., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.8183 · Cited by 873
Hata, A. N., & Breyer, R. M. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.06.003 · Cited by 840
H1-Receptor Antagonists: Comparative Tolerability and Safety
Estelle, F., & Simons, R. (1994) · Drug Safety · doi:10.2165/00002018-199410050-00002 · Cited by 751
Prostaglandin D 2 as a Mediator of Allergic Asthma
Matsuoka, T., Hirata, M., Tanaka, H., Takahashi, Y., Murata, T., Kabashima, K., Sugimoto, Y., Kobayashi, T., Ushikubi, F., Aze, Y., et al. (2000) · Science · doi:10.1126/science.287.5460.2013 · Cited by 743
Inflammatory Mediators in Late Antigen-Induced Rhinitis
Naclerio, R. M., Proud, D., Togias, A. G., Adkinson, N. F., Meyers, D. A., Kagey-Sobotka, A., Plaut, M., Norman, P. S., & Lichtenstein, L. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507113130201 · Cited by 692
Local Effects of Synthetic Leukotrienes (LTC4, LTD4, and LTB4) in Human Skin
Soter, N. A., Lewis, R. A., Corey, E. J., & Austen, K. F. (1983) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12531738 · Cited by 589
Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE.
Lewis, R. A., Soter, N. A., Diamond, P. T., Austen, K. F., Oates, J. A., & Roberts, L. J. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.4.1627 · Cited by 584
Mediator Release after Nasal Airway Challenge with Allergen
Naclerio, R. M., Creticos, P. S., Norman, P. S., & Lichtenstein, L. M. (1986) · American Review of Respiratory Disease · doi:10.1164/arrd.1986.134.5.1102 · Cited by 562
Role of prostaglandin-mediated vasodilatation in inflammation
WILLIAMS, T. J., & PECK, M. J. (1977) · Nature · doi:10.1038/270530a0 · Cited by 515
Kips, J. C., O'Connor, B. J., Langley, S. J., Woodcock, A., Kerstjens, H. A. M., Postma, D. S., Danzig, M., Cuss, F., & Pauwels, R. A. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200206-525oc · Cited by 494
Release of Prostaglandin D2into Human Airways during Acute Antigen Challenge
Murray, J. J., Tonnel, A. B., Brash, A. R., Roberts, L. J., Gosset, P., Workman, R., Capron, A., & Oates, J. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198609253151304 · Cited by 469
Williams, C. M. M., & Galli, S. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.455 · Cited by 400
Selective Expression of a Novel Surface Molecule by Human Th2 Cells In Vivo
Nagata, K., Tanaka, K., Ogawa, K., Kemmotsu, K., Imai, T., Yoshie, O., Abe, H., Tada, K., Nakamura, M., Sugamura, K., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1278 · Cited by 378
DAHLÉN, S.-E., MALMSTRÖM, K., NIZANKOWSKA, E., DAHLÉN, B., KUNA, P., KOWALSKI, M., LUMRY, W. R., PICADO, C., STEVENSON, D. D., BOUSQUET, J., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.1.2010080 · Cited by 330
Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor
Monneret, G., Gravel, S., Diamond, M., Rokach, J., & Powell, W. S. (2001) · Blood · doi:10.1182/blood.v98.6.1942 · Cited by 326
Effects of an antibody to interleukin-5 in a monkey model of asthma.
Mauser, P. J., Pitman, A. M., Fernandez, X., Foran, S. K., Adams, G. K., Kreutner, W., Egan, R. W., & Chapman, R. W. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.2.7633694 · Cited by 319
Wang, Y.-H., Ito, T., Wang, Y.-H., Homey, B., Watanabe, N., Martin, R., Barnes, C. J., McIntyre, B. W., Gilliet, M., Kumar, R., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.03.019 · Cited by 319
The Bronchoconstrictor Effect of Inhaled Prostaglandin D2 in Normal and Asthmatic Men
Hardy, C. C., Robinson, C., Tattersfield, A. E., & Holgate, S. T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407263110401 · Cited by 316
IL‐5‐induced airway eosinophilia – the key to asthma?
Hamelmann, E., & Gelfand, E. W. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.790118.x · Cited by 299
Nagata, K., Hirai, H., Tanaka, K., Ogawa, K., Aso, T., Sugamura, K., Nakamura, M., & Takano, S. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01251-x · Cited by 297
Cheng, K., Wu, T.-J., Wu, K. K., Sturino, C., Metters, K., Gottesdiener, K., Wright, S. D., Wang, Z., O’Neill, G., Lai, E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601574103 · Cited by 268
Xue, L., Gyles, S. L., Wettey, F. R., Gazi, L., Townsend, E., Hunter, M. G., & Pettipher, R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6531 · Cited by 261
Self-citationLack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice
Eguchi, N., Minami, T., Shirafuji, N., Kanaoka, Y., Tanaka, T., Nagata, A., Yoshida, N., Urade, Y., Ito, S., & Hayaishi, O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.726 · Cited by 237
Fujitani, Y., Kanaoka, Y., Aritake, K., Uodome, N., Okazaki-Hatake, K., & Urade, Y. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.443 · Cited by 225
Urade, Y., Ujihara, M., Horiguchi, Y., Ikai, K., & Hayaishi, O. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.9.2982 · Cited by 219
Emerging roles of DP and CRTH2 in allergic inflammation
Kostenis, E., & Ulven, T. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.02.005 · Cited by 216
Activation of the Prostaglandin D2 Receptor DP2/CRTH2 Increases Allergic Inflammation in Mouse
Spik, I., Brénuchon, C., Angéli, V., Staumont, D., Fleury, S., Capron, M., Trottein, F., & Dombrowicz, D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3703 · Cited by 213
Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets
Tanaka, K., Ogawa, K., Sugamura, K., Nakamura, M., Takano, S., & Nagata, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2277 · Cited by 204
Effect of Inhaled Prostaglandin E 2 on Allergen-induced Asthma
Pavord, I. D., Wong, C. S., Williams, J., & Tattersfield, A. E. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.1.87 · Cited by 200
INFLAMMATORY EFFECTS OF PROSTAGLANDIN D2 IN RAT AND HUMAN SKIN
FLOWER, R. J., HARVEY, E. A., & KINGSTON, W. P. (1976) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1976.tb07446.x · Cited by 195
Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2
Sawyer, N., Cauchon, E., Chateauneuf, A., Cruz, R. P. G., Nicholson, D. W., Metters, K. M., O'Neill, G. P., & Gervais, F. G. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704973 · Cited by 194
Hammad, H., Jan de Heer, H., Soullie, T., Hoogsteden, H. C., Trottein, F., & Lambrecht, B. N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.3936 · Cited by 194
Satoh, T., Moroi, R., Aritake, K., Urade, Y., Kanai, Y., Sumi, K., Yokozeki, H., Hirai, H., Nagata, K., Hara, T., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2621 · Cited by 194
Giles, H., Leff, P., Bolofo, M. L., Kelly, M. G., & Robertson, A. D. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb11816.x · Cited by 192
Doyle, W. J., Boehm, S., & Skoner, D. P. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(05)80156-3 · Cited by 190
Ajuebor, M. N., Singh, A., & Wallace, J. L. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.1.g238 · Cited by 168
Benyon, R. C., Robinson, C., & Church, M. K. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb12030.x · Cited by 165
O’Sullivan, S., Dahlén, B., Dahlén, S.-E., & Kumlin, M. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70167-7 · Cited by 163
Schulman, E. S., Newball, H. H., Demers, L. M., Fitzpatrick, F. A., & Adkinson, N. F. (1981) · PubMed · doi:10.1164/arrd.1981.124.4.402 · Cited by 163
Prostaglandin D2 and sleep regulation
Urade, Y., & Hayaishi, O. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s0005-2760(98)00163-5 · Cited by 162
Bochenek, G., Nagraba, K., Niżankowska, E., & Szczeklik, A. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1387 · Cited by 160
Sugimoto, H., Shichijo, M., Iino, T., Manabe, Y., Watanabe, A., Shimazaki, M., Gantner, F., & Bacon, K. B. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046748 · Cited by 159
Sousa, A. R., Pfister, R., Christie, P. E., Lane, S. J., Nasser, S. M., Schmitz-Schumann, M., & Lee, T. H. (1997) · Thorax · doi:10.1136/thx.52.11.940 · Cited by 155
Cutting Edge: Agonistic Effect of Indomethacin on a Prostaglandin D2 Receptor, CRTH2
Hirai, H., Tanaka, K., Takano, S., Ichimasa, M., Nakamura, M., & Nagata, K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.981 · Cited by 148
Role of Prostanoid DP Receptor Variants in Susceptibility to Asthma
Oguma, T., Palmer, L. J., Birben, E., Sonna, L. A., Asano, K., & Lilly, C. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031785 · Cited by 145
Gyllfors, P., Bochenek, G., Overholt, J., Drupka, D., Kumlin, M., Sheller, J. R., Niżankowska, E., Isakson, P. C., Mejza, F., Lefkowith, J. B., et al. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1450 · Cited by 143
Prostanoid‐induced contraction of human bronchial smooth muscle is mediated by TP‐receptors
Coleman, R. A., & Sheldrick, R. L. G. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb11869.x · Cited by 143
Prevention of Allergic Inflammation by a Novel Prostaglandin Receptor Antagonist, S-5751
Arimura, A., Yasui, K., Kishino, J., Asanuma, F., Hasegawa, H., Kakudo, S., Ohtani, M., & Arita, H. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29398-8 · Cited by 142
Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils
Raible, D. G., Schulman, E. S., DiMuzio, J. M., et al. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.11.3536 · Cited by 137
Liston, T. E., & Roberts, L. J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.18.6030 · Cited by 136
Trivedi, S. G., Newson, J., Rajakariar, R., Jacques, T. S., Hannon, R., Kanaoka, Y., Eguchi, N., Colville‐Nash, P., & Gilroy, D. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507175103 · Cited by 136
Raud, J., Dahlén, S., SYDBOM, A., Lindbom, L., & Hedqvist, P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2315 · Cited by 125
Effects of prostaglandin D2 on helper T cell functions
Tanaka, K., Hirai, H., Takano, S., Nakamura, M., & Nagata, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.151 · Cited by 119
Charlesworth, E. N., Kagey-Sobotka, A., Schleimer, R. P., Norman, P. S., & Lichtenstein, L. M. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.2.671 · Cited by 115
15-Deoxy-Δ12,1412,14-prostaglandins D2 and J2 Are Potent Activators of Human Eosinophils
Monneret, G., Li, H., Vasilescu, J., Rokach, J., & Powell, W. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3563 · Cited by 113
Sturm, E. M., Sturm, G. J., Weiglhofer, I., Sandig, H., Shichijo, M., McNamee, A., Pease, J. E., Kollroser, M., Peskar, B. A., & Heinemann, Á. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310270200 · Cited by 110
Heinemann, Á., Schuligoi, R., Sabroe, I., Hartnell, A., & Peskar, B. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4752 · Cited by 108
Beasley, R. W., Robinson, C., Featherstone, R. L., Varley, J. G., Hardy, C., Church, M. K., & Holgate, S. T. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112909 · Cited by 98
Huang, J., Gao, P.-S., Mathias, R. A., Yao, T., Chen, L., Kuo, M., Hsu, S., Plunkett, B., Togias, A. G., Barnes, K. C., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh279 · Cited by 96
Activation of the D Prostanoid Receptor 1 Regulates Immune and Skin Allergic Responses
Angeli, V., Staumont-Sallé, D., Charbonnier, A.-S., Hammad, H., Gosset, P., Pichavant, M., Lambrecht, B. N., Capron, M., Dombrowicz, D., & Trottein, F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3822 · Cited by 94
Studies on the ocular pharmacology of prostaglandin D2.
Woodward, D. F., HAWLEY, S. B., Williams, L. S., et al. (1990) · PubMed · Cited by 86
Chevalier, É., Stock, J., Fisher, T., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2056 · Cited by 84
Abé, H., Takeshita, T., Nagata, K., Arita, T., Endo, Y., Fujita, T., Takayama, H., Kubo, M., & Sugamura, K. (1999) · Gene · doi:10.1016/s0378-1119(98)00599-x · Cited by 84
Expression and Molecular Pharmacology of the Mouse CRTH2 Receptor
Hata, A. N., Zent, R., Breyer, M. D., & BREYER, R. M. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.050955 · Cited by 77
Monitoring mast cell activation by prostaglandin D2 in vivo
Dahlen, S.-E. (2004) · Thorax · doi:10.1136/thx.2004.026641 · Cited by 77
Anti-Interleukin-5 Monoclonal Antibodies: Preclinical and Clinical Evidence in Asthma Models
Leckie, M. J. (2003) · American Journal of Respiratory Medicine · doi:10.1007/bf03256653 · Cited by 74
Prostaglandin D2 causes accumulation of eosinophils in the lumen of the dog trachea
Emery, D. L., Djokic, T. D., Graf, P. D., & Nadel, J. A. (1989) · Journal of Applied Physiology · doi:10.1152/jappl.1989.67.3.959 · Cited by 73
Effect of indomethacin on allergen-induced asthmatic responses
Kirby, J. G., Hargreave, F. E., Cockcroft, D. W., et al. (1989) · Journal of Applied Physiology · doi:10.1152/jappl.1989.66.2.578 · Cited by 73
Nantel, F., Fong, C., Lamontagne, S., Wright, D. H., Giaid, A., Desrosiers, M. Y., Metters, K. M., O’Neill, G. P., & Gervais, F. G. (2004) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2003.12.002 · Cited by 72
CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation
Takeshita, K., Yamasaki, T., Nagao, K., Sugimoto, H., Shichijo, M., Gantner, F., & Bacon, K. B. (2004) · International Immunology · doi:10.1093/intimm/dxh096 · Cited by 72
A physicogenetic method to assign ligand-binding relationships between 7TM receptors
Frimurer, T. M., Ulven, T., Elling, C., Gerlach, L., Kostenis, E., & Högberg, T. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.102 · Cited by 66
Shichijo, M., Sugimoto, H., Nagao, K., Inbe, H., Encinas, J. A., Takeshita, K., Bacon, K. B., & Gantner, F. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.055442 · Cited by 64
Gosset, P., Pichavant, M., Faveeuw, C., Bureau, F., Tonnel, A., & Trottein, F. (2005) · European Journal of Immunology · doi:10.1002/eji.200425319 · Cited by 63
Activation of nuclear receptors by prostaglandins
Ide, T., Egan, K. M., Bell, L. C., & FitzGerald, G. A. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00418-3 · Cited by 63
Effects of intravenous infusions of prostaglandin D2 in man
Heavey, D. J., Lumley, P., Barrow, S. E., Murphy, M. B., Humphrey, P. P. A., & Dollery, C. T. (1984) · Prostaglandins · doi:10.1016/0090-6980(84)90033-9 · Cited by 62
Faveeuw, C., Gosset, P., Bureau, F., Angéli, V., Hirai, H., Maruyama, T., Narumiya, S., Capron, M., & Trottein, F. (2003) · European Journal of Immunology · doi:10.1002/eji.200323330 · Cited by 58
Mathiesen, J. M., Christopoulos, A., Ulven, T., Royer, J. F., Campillo, M., Heinemann, Á., Pardo, L., & Kostenis, E. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.017681 · Cited by 57
9α,11β‐PGF2 and its stereoisomer PGF2α are novel agonists of the chemoattractant receptor, CRTH2
Sandig, H., Andrew, D. P., Barnes, A. A., Sabroe, I., & Pease, J. E. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.11.052 · Cited by 51
Gazi, L., Gyles, S. L., Rose, J., Lees, S., Allan, C., Xue, L., Jassal, R., Speight, G., Gamble, V., & Pettipher, R. (2005) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.11.003 · Cited by 47
Self-citationJohnston, S. L., Pg, B., Harrison, J., Ritter, W., Joubert, J., & Holgate, S. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb05649.x · Cited by 45
Small-molecule CRTH2 antagonists for the treatment of allergic inflammation: an overview
Ly, T. W., & Bacon, K. B. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.7.769 · Cited by 35
Johnston, S. L., Smith, S. R., Harrison, J. E., Ritter, W., & Howarth, P. H. (1993) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(93)90348-j · Cited by 32
Hata, A. N., Lybrand, T. P., Marnett, L. J., & BREYER, R. M. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.007971 · Cited by 25
Isosteric ramatroban analogs: selective and potent CRTH-2 antagonists
Robarge, M. J., Bom, D. C., Tumey, L. N., Varga, N., Gleason, E., Silver, D., Song, J., Murphy, S. M., Ekema, G., Doucette, C., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.12.055 · Cited by 24
Recent Progress in Work on PGD2 Antagonists for Drugs Targeting Allergic Diseases
Mitsumori, S. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043382864 · Cited by 19
Jarad, N. A., Hui, K., & Barnes, N. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04249.x · Cited by 16
Cited by
Wymann, M. P., & Schneiter, R. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2335 · Cited by 1,291
Resolution of inflammation: a new therapeutic frontier
Fullerton, J. N., & Gilroy, D. W. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.39 · Cited by 937
Health Implications of High Dietary Omega-6 Polyunsaturated Fatty Acids
Patterson, E., Wall, R., Fitzgerald, G. F., Ross, R. P., & Stanton, C. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/539426 · Cited by 883
Synopsis of arachidonic acid metabolism: A review
Hanna, V. S., & Hafez, E. A. A. (2018) · Journal of Advanced Research · doi:10.1016/j.jare.2018.03.005 · Cited by 596
Prostanoids in health and disease
Smyth, E. M., Grosser, T., Wang, M., Yu, Y., & FitzGerald, G. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800094-jlr200 · Cited by 543
Metadata
- Authors
- Pettipher, R., Hansel, T. T., & Armer, R.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-04
- Volume
- 6
- Issue
- 4
- Pages
- 313-325
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2078915983
- Cited by
- 317
- References
- 92
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.